SOX9 antibody
-
- Target See all SOX9 Antibodies
- SOX9 (SRY (Sex Determining Region Y)-Box 9 (SOX9))
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This SOX9 antibody is un-conjugated
-
Application
- Western Blotting (WB), Immunofluorescence (IF), Enzyme Immunoassay (EIA)
- Specificity
- Recognizes SOX9
- Cross-Reactivity (Details)
- Species reactivity (tested):Human.
- Purification
- Purified
- Clone
- 1B11
- Isotype
- IgG1
- Top Product
- Discover our top product SOX9 Primary Antibody
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1.0 mg/mL
- Buffer
- PBS, 0.05 % Sodium Azide, 0.5 % protein stabilizer
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
- Target
- SOX9 (SRY (Sex Determining Region Y)-Box 9 (SOX9))
- Alternative Name
- SOX9 (SOX9 Products)
- Background
- The protein encoded by this gene recognizes the sequence CCTTGAG along with other members of the HMG-box class DNA-binding proteins. It acts during chondrocyte differentiation and, with steroidogenic factor 1, regulates transcription of the anti-Muellerian hormone (AMH) gene. Deficiencies lead to the skeletal malformation syndrome campomelic dysplasia, frequently with sex reversal.Synonyms: CMD1, CMPD1, SRA1, SRY (sex determining region Y)-box 9, SRY-box 9, Transcription factor SOX-9
- Molecular Weight
- 56 kDa
- Gene ID
- 6662
- Pathways
- EGFR Signaling Pathway, Stem Cell Maintenance, Regulation of Muscle Cell Differentiation, Tube Formation, Skeletal Muscle Fiber Development
-